Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HMPL-A580 in Advanced or Metastatic Solid Tumors
NCT07396584Phase 2Recruiting
- Sponsor
- HUTCHMED
- Start
- Mar 2026
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of HMPL-A580 in solid tumor, sponsored by HUTCHMED. Started Mar 2026; status: recruiting.
02
Drugs
HMPL-A580
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07396584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07396584.